Singapore markets closed

Straits Times Index
3,292.69
+10.64(+0.32%)
Nikkei
38,274.05
-131.61(-0.34%)
Hang Seng
17,763.03
+16.12(+0.09%)
FTSE 100
8,144.13
-2.90(-0.04%)
Bitcoin USD
59,674.23
-3,702.43(-5.84%)
CMC Crypto 200
1,283.00
-56.07(-4.19%)

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed price. Currency in KRW

Add to watchlist

781,000.00

+6,000.00

(+0.77%)

At close: 03:30PM KST

Loading interactive chart…

PR Newswire
Samsung Biologics Reports First Quarter 2024 Financial Results
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024.
PR Newswire
Samsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)
Samsung Life Science Fund, created jointly between Samsung Biologics (KRX: 207940.KS), Samsung Bioepis, and Samsung C&T (KRX: 028260.KS), and managed by Samsung Ventures, and BrickBio, Inc. announced Samsung's investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code.
Thomson Reuters StreetEvents
Q4 2023 Rapid Micro Biosystems Inc Earnings Call
Q4 2023 Rapid Micro Biosystems Inc Earnings Call